- Home
- ALDX vs PUBM Comparison
ALDX vs PUBM Comparison
Compare ALDX & PUBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- PUBM
- Stock Information
- Founded
- ALDX 2004
- PUBM 2006
- Country
- ALDX United States
- PUBM United States
- Employees
- ALDX N/A
- PUBM N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- PUBM Computer Software: Prepackaged Software
- Sector
- ALDX Health Care
- PUBM Technology
- Exchange
- ALDX Nasdaq
- PUBM Nasdaq
- Market Cap
- ALDX 326.6M
- PUBM 382.7M
- IPO Year
- ALDX 2014
- PUBM 2020
- Fundamental
- Price
- ALDX $5.81
- PUBM $9.07
- Analyst Decision
- ALDX Strong Buy
- PUBM Buy
- Analyst Count
- ALDX 2
- PUBM 11
- Target Price
- ALDX $9.50
- PUBM $18.05
- AVG Volume (30 Days)
- ALDX 917.6K
- PUBM 940.0K
- Earning Date
- ALDX 08-07-2025
- PUBM 08-11-2025
- Dividend Yield
- ALDX N/A
- PUBM N/A
- EPS Growth
- ALDX N/A
- PUBM N/A
- EPS
- ALDX N/A
- PUBM N/A
- Revenue
- ALDX N/A
- PUBM $292,208,000.00
- Revenue This Year
- ALDX N/A
- PUBM $2.80
- Revenue Next Year
- ALDX $29.89
- PUBM $10.43
- P/E Ratio
- ALDX N/A
- PUBM N/A
- Revenue Growth
- ALDX N/A
- PUBM 3.53
- 52 Week Low
- ALDX $1.14
- PUBM $7.01
- 52 Week High
- ALDX $7.20
- PUBM $17.74
- Technical
- Relative Strength Index (RSI)
- ALDX 71.16
- PUBM 39.25
- Support Level
- ALDX $5.34
- PUBM $7.80
- Resistance Level
- ALDX $5.73
- PUBM $8.63
- Average True Range (ATR)
- ALDX 0.27
- PUBM 0.52
- MACD
- ALDX 0.01
- PUBM -0.13
- Stochastic Oscillator
- ALDX 77.36
- PUBM 42.39
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About PUBM PubMatic Inc.
PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.